Skip to search formSkip to main contentSkip to account menu

telaprevir

Known as: (1S,3AR,6as)-(2S)-2-cyclohexyl-N-(pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-((1S)-1-((cyclopropylamino)oxoacetyl)butyl)octahydrocyclopenta(c)pyrrole-1-carboxamide 
An orally available peptidomimetic small molecule with activity against hepatitis C virus (HCV). Telaprivir is a selective protease inhibitor that… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Background: Telaprevir is a protease inhibitor used in the treatment of hepatitis C virus infection. Analytical methods for… 
2014
2014
The aim of the present study was to predict sustained virological response (SVR) to telaprevir with pegylated interferon (PEG-IFN… 
2013
2013
Gilead has filed the first interferon-free hepatitis C virus regimen for approval in the United States, but drug developers are… 
2013
2013
The landscape of therapy for hepatitis C virus (HCV) infection is changing rapidly. Until recently, the standard of care for HCV… 
2013
2013
s of the Fifty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, USA, 2011. Abstract 1738a… 
2012
2012
Cirrhosis from Hepatitis C (HCV) remains the leading indication for liver transplantation in the United States with recurrent… 
2012
2012
Background: Previous studies have reported telaprevir is effective for chronic hepatitis C virus infection, but the safety of a… 
2010
2010
Data from a late-stage trial of the most advanced of a new class of drugs targeting the hepatitis C virus protease fuel hopes for… 
2009
2009
n engl j med 361;5 nejm.org july 30, 2009 533 Madrid AH, Bueno MG, Rebollo JM, et al. Use of irbesartan 1. to maintain sinus…